Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma

被引:12
|
作者
Min, Wen-Pu [1 ]
Wei, Xiao-Feng [1 ]
机构
[1] Yangtze Univ, Peoples Hosp Jingzhou City 1, Dept Nucl Med, Affiliated Hosp 1, Jingzhou 434000, Hubei, Peoples R China
关键词
Papillary thyroid carcinoma; SIX1; TGF-beta/Smad2/3; Epithelial mesenchymal transition; POOR-PROGNOSIS; CANCER; EXPRESSION; GROWTH; EMT; METASTASIS; CELLS; OVEREXPRESSION; ACTIVATION; TGF-BETA-1;
D O I
10.1016/j.anl.2020.10.002
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To investigate the sineoculis homeobox homolog 1 (SIX1) affect the epithelial mesenchymal transition (EMT) in papillary thyroid carcinoma (PTC) through regulating TGF-beta/Smad2/3 signaling pathway. Methods: The SIX1 expression in cytological specimens, tissues or PTC cell lines was detected by qRT-PCR, western blotting or immunohistochemistry. A series of vitro experiments including flow cytometry, CCK-8, wound-healing and Transwell were used to evaluate the biological characteristics in a PTC cell line (NPA cells), which were divided into Blank, Negative control (NC), SIX1, SIX1-siRNA, LY-364947 (TGF-beta/Smad2/3 pathway inhibitor) and SIX1 + LY364947 groups. TGF-beta/Smad2/3 pathway and EMT related protein expression were measured by qRT-PCR and western blotting. Results: SIX1 mRNA expression was increased in cytological specimens from PTC patients as compared with the non-toxic nodular goitre (NTG) patients. Moreover, compared with adjacent normal tissues, expressions of SIX1, N-cadherin and Vimentin were higher while E-cadherin was lower in PTC tissues; and SIX1 was positively correlated with N-cadherin and Vimentin but was negatively correlated with E-cadherin. Furthermore, the SIX1 expression was associated with histopathology, extrathyroidal extension (ETE), lymph node metastasis (LNM), pT stage, TNM stage, and distant metastasis. In addition, the expressions of TGF-beta 1, p-SMAD2/3, N-cadherin and Vimentin were downregulated in NPA cells after LY-364947 treatment with upregulated Ecadherin, decreased cell proliferation and metastasis, and enhanced cell apoptosis, which was reversed by SIX1 overexpression. Conclusion: Silencing SIX1 can inhibit TGF-beta/Smad2/3 pathway, thereby suppressing EMT in PTC, which may be a novel avenue for the treatment of PTC. (C) 2020 Oto-Rhino-Laryngological Society of Japan Inc. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [21] Six1 Promotes Epithelial-Mesenchymal Transition in Bronchial Epithelial Cells via the TGFβ1/Smad Signalling Pathway
    Wang, Wenxin
    Yang, Zhaochuan
    Li, Meixiang
    Wang, Zhenhong
    Shan, Yanchun
    Qu, Zhenghai
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2021, 182 (06) : 479 - 488
  • [22] S100A11 promotes TGF-β1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma
    Zhang, Meixia
    Zheng, Susu
    Jing, Chuyu
    Zhang, Juan
    Shen, Hujia
    Xu, Xin
    Lin, Jiajia
    Zhang, Boheng
    FUTURE ONCOLOGY, 2018, 14 (09) : 837 - 847
  • [23] GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway
    Yang, Han-Jie
    Liu, Ge-Liang
    Liu, Bo
    Liu, Tian
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (03) : 1650 - 1665
  • [24] Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway
    Fan, Qiong
    Qiu, Met-Ting
    Zhu, Zhu
    Zhou, Jin-Hua
    Chen, Limo
    Zhou, Ye
    Gu, Wei
    Wang, Li-Hua
    L, Zhu-Nan, I
    Xu, Ying
    Cheng, Wei-Wei
    Wu, Dan
    Bao, Wei
    ONCOLOGY REPORTS, 2015, 34 (04) : 1787 - 1794
  • [25] FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway
    Ma, Siyuan
    Wang, Qingzhu
    Ma, Xiaojun
    Wu, Lina
    Guo, Feng
    Ji, Hongfei
    Liu, Fei
    Zhao, Yanyan
    Qin, Guijun
    TUMOR BIOLOGY, 2016, 37 (01) : 989 - 998
  • [26] Sirtuin 6 inhibits MWCNTs-induced epithelial-mesenchymal transition in human bronchial epithelial cells via inactivating TGF-β1/Smad2 signaling pathway
    Chen, Panpan
    Tian, Kunming
    Tu, Wei
    Zhang, Qian
    Han, Lianyong
    Zhou, Xue
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 374 : 1 - 10
  • [27] TSLP Induces Epithelial-Mesenchymal Transition in Nasal Epithelial Cells From Allergic Rhinitis Patients Through TGF-β1/Smad2/3 Signaling
    Yu, Hong Wei
    Wang, Wei Wei
    Jing, Qian
    Pan, Yong Liang
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2023, 37 (06) : 739 - 750
  • [28] MFAP2 promotes epithelial-mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway
    Wang, Jian-Kai
    Wang, Wen-Juan
    Cal, Hong-Yi
    Du, Bin-Bin
    Mai, Ping
    Zhang, Li-Juan
    Ma, Wen
    Hu, Yong-Guo
    Feng, Shi-Fang
    Miao, Guo-Ying
    ONCOTARGETS AND THERAPY, 2018, 11 : 4001 - 4017
  • [29] Naringenin inhibits autophagy and epithelial-mesenchymal transition of human lens epithelial cells by regulating the Smad2/3 pathway
    Li, Qingnan
    Liu, Shuang
    Yang, Guang
    Li, Mingming
    Qiao, Peng
    Xue, Qiang
    DRUG DEVELOPMENT RESEARCH, 2022, 83 (02) : 389 - 396
  • [30] AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition
    Lin, Hui
    Li, Nianshuang
    He, Huan
    Ying, Ying
    Sunkara, Shashank
    Luo, Lingyu
    Lv, Nonghua
    Huang, Deqiang
    Luo, Zhijun
    MOLECULAR PHARMACOLOGY, 2015, 88 (06) : 1062 - 1071